These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 6695656
1. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate. Nathan AW, Hellestrand KJ, Bexton RS, Banim SO, Spurrell RA, Camm AJ. Am Heart J; 1984 Feb; 107(2):222-8. PubMed ID: 6695656 [Abstract] [Full Text] [Related]
3. A comparison of the antiarrhythmic effects on AV junctional re-entrant tachycardia of oral and intravenous flecainide acetate. Bexton RS, Hellestrand KJ, Nathan AW, Spurrell RA, Camm AJ. Eur Heart J; 1983 Feb; 4(2):92-102. PubMed ID: 6852073 [Abstract] [Full Text] [Related]
4. Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram. Morganroth J, Horowitz LN. Am J Cardiol; 1984 Feb 27; 53(5):89B-94B. PubMed ID: 6695821 [Abstract] [Full Text] [Related]
11. Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man. Hellestrand KJ, Bexton RS, Nathan AW, Spurrell RA, Camm AJ. Br Heart J; 1982 Aug 25; 48(2):140-8. PubMed ID: 7093083 [Abstract] [Full Text] [Related]
12. Flecainide: a new prototype antiarrhythmic agent. Nappi JM, Anderson JL. Pharmacotherapy; 1985 Aug 25; 5(4):209-21. PubMed ID: 3898035 [Abstract] [Full Text] [Related]
13. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG. Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395 [Abstract] [Full Text] [Related]